Package 69423-990-12

{"route": ["ORAL"], "spl_id": "402e2e59-c1b7-8c3c-e063-6294a90a9615", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1369842"], "spl_set_id": ["ef6e8503-d268-291b-e053-2995a90aec8f"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "236 mL in 1 BOTTLE, PLASTIC (69423-990-08)", "package_ndc": "69423-990-08", "marketing_start_date": "20210322"}, {"sample": false, "description": "354 mL in 1 BOTTLE, PLASTIC (69423-990-12)", "package_ndc": "69423-990-12", "marketing_start_date": "20210322"}], "brand_name": "DayQuil VapoCOOL SEVERE COLD and FLU plus CONGESTION", "product_id": "69423-990_402e2e59-c1b7-8c3c-e063-6294a90a9615", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "69423-990", "generic_name": "acetaminophen, phenylephrine hydrochloride, dextromethorphan hydrobromide, and guaifenesin", "labeler_name": "The Procter & Gamble Manufacturing Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "DayQuil VapoCOOL SEVERE", "brand_name_suffix": "COLD and FLU plus CONGESTION", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "650 mg/30mL"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "20 mg/30mL"}, {"name": "GUAIFENESIN", "strength": "400 mg/30mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "10 mg/30mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210322", "listing_expiration_date": "20261231"}